4839: Indian stocks tumble, RBI defends Rupee, MiG 21 bows out & more | MC Editor's Picks

Trump’s 100% tariff threat on branded or patented drugs causes the Nifty pharma index to tumble, compounding the stress of a tough week for Indian stocks. In Moneycontrol Pro, we examine how the balancing act between defending the rupee and preserving liquidity has become trickier than ever for RBI. Find our piece on a quirky anomaly that has crept in after the latest tax rationalisation. And other news: MiG 21 flies into the sunset, government monitors impact of GST rate cuts and Indians face the brunt of the West’s anti-immigration sentiment.